Biotech news continually updated from thousands of sources around the net.
1 hr ago | Reuters
Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, estimates its pipeline of so-called new therapeutic entities could generate revenue of $1 billion to $1.5 billion by 2018.
Should states get to ban abortion?
Should religious groups be tax exempt?
6 hrs ago | The Paducah Sun Online Edition
Jose Luis Alonso, 68, of Paducah, passed away at 1:52 p.m. Thursday, December 5, 2013, at Baptist Health Paducah.
Gilead Sciences, Inc. today announced interim results from a single-arm, open-label Phase 2 study evaluating GS-9973, an investigational oral inhibitor of spleen tyrosine kinase , for the treatment of patients with relapsed or refractory hematologic malignancies.
SAC Capital Advisors LP founder Steven Cohen may help former fund manager Mathew Martoma defend against insider-trading charges next month at trial even if Cohen asserts his legal right to avoid testifying.
In this Thursday, Nov. 14, 2013, file photo, retired U.S. Air Force Master Sgt. Thomas Gipson, of Atlanta, right, has his resume looked over by Ralph Brown, a management and program analyst with the Centers for Disease Control and Prevention, during a job fair for veterans at the VFW Post 2681,Marietta, Ga.
A long-awaited study by the U.S. Centers for Disease Control and Prevention confirms a link between tainted tap water at a U.S. Marine Corps base in North Carolina and increased risk of serious birth defects and childhood cancers.
U.S. health regulators on Friday approved Auxilium Pharmaceuticals Inc's Xiaflex injections to treat a condition that causes a painful curvature of the penis called Peyronie's disease.
Colossus Minerals Inc. . Miner. Down 8.5 cents, or 34 per cent, at 16.5 cents on 10.05 million shares.
Gilead Sciences Inc. says the U.S. government has approved its highly anticipated hepatitis C drug that is expected to offer a faster cure to millions of people infected with the liver-destroying virus.
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
Theravance and GlaxoSmithKline said today that their lung disease drug Breo Ellipta worked as a treatment for asthma in a clinical trial.
GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial.
Bausch + Lomb Inc.'s parent company said Thursday it had made further cuts to B+L's Rochester-area workforce.
Small stocks have brought big joy this year, but they've been so generous that some mutual fund managers question how much they have left to give.
Eli Lilly said Thursday its depression drug edivoxetine failed in late-stage clinical testing, and it doesn't plan to file for marketing approval of the drug.
New York Mayor Michael Bloomberg administration's is using its final days to cement its vision the city as an economic epicenter for the life sciences industry.